BG27380A3 - Method of obtaining of erythromycilamine derivaties - Google Patents

Method of obtaining of erythromycilamine derivaties

Info

Publication number
BG27380A3
BG27380A3 BG7632727A BG3272776A BG27380A3 BG 27380 A3 BG27380 A3 BG 27380A3 BG 7632727 A BG7632727 A BG 7632727A BG 3272776 A BG3272776 A BG 3272776A BG 27380 A3 BG27380 A3 BG 27380A3
Authority
BG
Bulgaria
Prior art keywords
erythromycilamine
derivaties
obtaining
erythromycilamine derivaties
Prior art date
Application number
BG7632727A
Other languages
Bulgarian (bg)
English (en)
Inventor
Maier
Woitun
Wetzel
Reuter
Goeth
Leichner
Original Assignee
Dr Karl Thomae Gmbh,De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25768725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG27380(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2515075A external-priority patent/DE2515075C2/de
Priority claimed from DE19762606030 external-priority patent/DE2606030A1/de
Application filed by Dr Karl Thomae Gmbh,De filed Critical Dr Karl Thomae Gmbh,De
Publication of BG27380A3 publication Critical patent/BG27380A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG7632727A 1975-04-07 1976-03-29 Method of obtaining of erythromycilamine derivaties BG27380A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2515075A DE2515075C2 (de) 1975-04-07 1975-04-07 Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19762606030 DE2606030A1 (de) 1976-02-14 1976-02-14 Neue erythromycinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
BG27380A3 true BG27380A3 (en) 1979-10-12

Family

ID=25768725

Family Applications (1)

Application Number Title Priority Date Filing Date
BG7632727A BG27380A3 (en) 1975-04-07 1976-03-29 Method of obtaining of erythromycilamine derivaties

Country Status (29)

Country Link
US (1) US4048306A (fr)
JP (1) JPS51128991A (fr)
AT (1) AT342770B (fr)
AU (1) AU498418B2 (fr)
BG (1) BG27380A3 (fr)
CA (1) CA1060005A (fr)
CH (2) CH621800A5 (fr)
CS (1) CS196304B2 (fr)
DD (1) DD125218A5 (fr)
DK (1) DK138656C (fr)
ES (2) ES446737A1 (fr)
FI (1) FI63244C (fr)
FR (1) FR2306703A1 (fr)
GB (1) GB1520963A (fr)
GR (1) GR60374B (fr)
HU (1) HU175186B (fr)
IE (1) IE43598B1 (fr)
IL (1) IL49359A (fr)
LU (2) LU88563I2 (fr)
MX (1) MX3277E (fr)
NL (1) NL180107C (fr)
NO (1) NO141411C (fr)
NZ (1) NZ180529A (fr)
PL (1) PL101880B1 (fr)
PT (1) PT64977B (fr)
RO (1) RO68441B (fr)
SE (1) SE425566B (fr)
SU (1) SU682134A3 (fr)
YU (1) YU87676A (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES552858A1 (es) 1985-03-12 1987-11-01 Beecham Group Plc Un procedimiento para la preparacion de derivados de eritromicina.
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
US4945080A (en) * 1987-05-26 1990-07-31 Eli Lilly And Company Dirithromycin metabolite
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
DE69127457T2 (de) * 1990-11-28 1998-01-22 Taisho Pharmaceutical Co Ltd 6-0-methylerythromycin a-derivat
ZA922776B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical compounds
US5556839A (en) * 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
IL103276A (en) * 1991-09-30 1997-06-10 Lilly Co Eli One-step process for production of dirithromycin
DE4410637C1 (de) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injizierbare Lösungen von Dirithromycin
AU9645998A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US6436906B1 (en) 2001-04-02 2002-08-20 Enanta Pharmaceuticals, Inc. 9-amino-14-membered macrolides derived from leucomycins
WO2005009364A2 (fr) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Produit antibiotique, utilisation et formulation associees
CA2533178C (fr) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Produit antibiotique, son utilisation et sa formulation
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005016311A1 (fr) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Pastille robuste
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004270170B2 (en) * 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660376A (en) * 1970-09-30 1972-05-02 Lilly Co Eli N-arylidene erythromycylamines

Also Published As

Publication number Publication date
PT64977B (de) 1978-04-03
SE7604052L (sv) 1976-10-08
AT342770B (de) 1978-04-25
LU74702A1 (fr) 1977-06-03
RO68441B (ro) 1983-04-30
NL7603569A (nl) 1976-10-11
AU1272276A (en) 1977-10-13
DK138656C (da) 1979-04-02
JPS62158B2 (fr) 1987-01-06
PT64977A (de) 1976-05-01
GR60374B (en) 1978-05-23
IE43598B1 (en) 1981-04-08
DD125218A5 (de) 1977-04-06
ES446737A1 (es) 1977-10-16
FI63244C (fi) 1983-05-10
NL180107C (nl) 1987-01-02
RO68441A (fr) 1983-04-29
DK138656B (da) 1978-10-09
CA1060005A (fr) 1979-08-07
HU175186B (hu) 1980-05-28
FI760845A (fr) 1976-10-08
SU682134A3 (ru) 1979-08-25
NO761172L (fr) 1976-10-08
FR2306703A1 (fr) 1976-11-05
CH621800A5 (fr) 1981-02-27
FI63244B (fi) 1983-01-31
AU498418B2 (en) 1979-03-15
CS196304B2 (en) 1980-03-31
CH624413A5 (fr) 1981-07-31
NL180107B (nl) 1986-08-01
YU87676A (en) 1982-08-31
US4048306A (en) 1977-09-13
NO141411B (no) 1979-11-26
LU88563I2 (fr) 1995-03-21
PL101880B1 (pl) 1979-02-28
DK145276A (da) 1976-10-08
NO141411C (no) 1980-03-05
NZ180529A (en) 1978-09-20
FR2306703B1 (fr) 1979-10-12
ATA149976A (de) 1977-08-15
JPS51128991A (en) 1976-11-10
ES456567A1 (es) 1978-03-01
IE43598L (en) 1976-10-07
IL49359A (en) 1979-07-25
GB1520963A (en) 1978-08-09
IL49359A0 (en) 1976-06-30
SE425566B (sv) 1982-10-11
MX3277E (es) 1980-08-15

Similar Documents

Publication Publication Date Title
BG27553A3 (en) Method of obtaining of 2- phenyl- 3- aroylxenzothiophenes
BG27380A3 (en) Method of obtaining of erythromycilamine derivaties
BG24673A3 (en) Method of obtaining quinazone derivatives
BG27362A3 (en) Method of obtaining n- phenyl- n- benzoyl carbamides
BG27548A3 (en) Method of obtaining of carbonylsubstituated 1- sulphanylbenzimidazoles
BG27554A3 (en) Method of obtaining of derivatives of 2- aroyl- 3- phenyl- bewzothiophenes
BG27542A3 (en) Method of obtaining of 1- benzazolylalkyl- 4- substituated
BG24799A3 (en) Method of obtaining benzoylureidediphenyl-esters
BG27355A3 (en) Method of obtaining of 11- desoxy- 16- ariloxy- w- tetranoprostaglandines
JPS5280987A (en) Method of forming can
BG31070A3 (en) Method for obtaining of 11- dexoxy- 16- aryl- w- tetranoprostagine
BG27899A3 (en) Method of obtaining of highdispersed cianurchloride
BG27543A3 (en) Method of obtaining of n- aryl- n- (1- l- 4- piperidinyj)- arylacetamides
BG24801A3 (en) Method of obtaining l-pyroglutamyl-l-prolineamide
JPS5280397A (en) Popymerization method of epsilonncaprolactam
JPS51146407A (en) Method of producing 22aminoonnbutanol
BG27732A3 (en) Method of obtaining of di- substituated phenolethers of 3- amino- 2-hydroxipropane
JPS5253807A (en) Method of producing 22aminoo11alcohol
BG32846A3 (en) Method for obtaining of n- methylcarbamide
JPS51138618A (en) Method of producing iminodiacetonitlile
BG28057A4 (en) Method of obtaining of 3- hydroxy- methylenchromanones
BG27555A3 (en) Method of obtaining of derivatives of aroyl- phenilnaphtalenes
JPS5250560A (en) Method of forming throughhhole
BG27373A3 (en) Method of obtaining of gamapyrones
JPS51145588A (en) Method of continuous phtoopolymerization